Aspira Womans Health Inc (AWH) ニュース

Form 8-K - Current report

Form 8-K - Current report

Aspira Women’s Health Announces Appointment of Dr. Sandra Milligan as Interim CEO

AUSTIN, Texas, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”...

Aspira Women’s Health Successfully Reaches the First Milestone of the ARPA-H $10 Million Award

AUSTIN, Texas, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”) (NASDAQ: AWH), a...

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 4 - Statement of changes in beneficial ownership of securities

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form 8-K - Current report

Aspira Women’s Health Reports Selected Third Quarter 2024 Financial Results

Q3 2024 OvaSuiteSM revenue of $2.3 million and volume of 6,001 units Cash utilization for the third quarter...

Form 4 - Statement of changes in beneficial ownership of securities

Aspira Women’s Health Expands Co-Marketing and Distribution Collaboration with BioReference® to Include OvaWatch®

AUSTIN, Texas, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”) (NASDAQ: AWH), a...

Aspira Women’s Health to Announce Third Quarter Earnings Results and Host a Conference Call on Thursday, November 14, 2024

AUSTIN, Texas, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”...

Form 8-K - Current report